Hepatitis B vaccination in hemodialysis patients: different points of view for conclusion

Alavian, Seyed Moayed

doi:10.1590/s0101-28002011000300014

Cited by 1 publication

(1 citation statement)

References 4 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Depressed immunity intensifies the morbidity and mortality related to CKD; hence must not be ignored and must be the focus of research so that ways and means can be explored to minimize the CKD-related compromised quality and quantity of life. 6 CKD patients on hemodialysis (HD) are additionally exposed to blood-borne viral diseases, especially Hepatitis B (HB). This is a challenging issue, as a regular vaccination regime has been found inadequate and non-effective.…”

Section: Introductionmentioning

confidence: 99%

The Immune Response after Double Dose Hepatitis B Vaccination in Hemodialysis Patients: Influence of Age and Hepatitis C Virus

Asghar¹,

Abbasi²,

Hashmi³

et al. 2022

PAFMJ

View full text Add to dashboard Cite

Objective: To determine the efficacy of Hepatitis B vaccination among the candidates of maintenance hemodialysis due to chronic kidney disease and to measure the impact of ageing and Hepatitis C infection upon immune seroconversion. Study Design: Cross-sectional study. Place and Duration of Study: Nephrology Department, Multan Institute of Kidney Diseases (MIKD), Multan Pakistan from Jan to Jun 2020. Methodology: Two hundred male and female patients diagnosed with end-stage kidney disease on maintenance dialysis (more than three months) with the range of age, 15 to 70 years, were selected by non-probability consecutive sampling. Already treated patients of HB virus and those with HB virus detectable by ELISA were excluded from the study. Data was accessed through hospital management software records. Three months after the three or four completed doses, antiHBs titer was assessed by ELISA. Cut off the value of anti-Hbs titer was 10U/L to differentiate between responders and non-responders of HBV. Results: Among the 117 responders, 109 (93%) cases received four double doses of the vaccine, while only 8 (7%) were those who received three double doses. Among 83 non-responders, 52 (63%) were above age 40 years, while 31 (37%) were of age 40 years or below. In addition, among the non-responders, 63 (76%) were Hep C positive, while 20 (24%) were Hep C negative patients. Conclusions: Four double-dose vaccines have been effective for haemodialysis patients with end-stage kidney disease. Vaccine response is inversely correlated with age and Hepatitis C virus.

show abstract

Section: Introductionmentioning

confidence: 99%

The Immune Response after Double Dose Hepatitis B Vaccination in Hemodialysis Patients: Influence of Age and Hepatitis C Virus

Asghar¹,

Abbasi²,

Hashmi³

et al. 2022

PAFMJ

View full text Add to dashboard Cite

show abstract

Hepatitis B vaccination in hemodialysis patients: different points of view for conclusion

Abstract: The present letter to the editor shows the other aspect of Hepatitis B vaccination in hemodialysis patients.

Cited by 1 publication

References 4 publications

The Immune Response after Double Dose Hepatitis B Vaccination in Hemodialysis Patients: Influence of Age and Hepatitis C Virus

The Immune Response after Double Dose Hepatitis B Vaccination in Hemodialysis Patients: Influence of Age and Hepatitis C Virus

Contact Info

Product

Resources

About